InsidersTradesSigma
Track the Starling Oncology, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €628.8m. The latest transaction was filed on 24 August 2026 (Cession). Among the most active insiders: Hively Brad. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Starling Oncology, Inc. is a company focused on developing innovative cancer treatments. It is listed on the XNAS market.